UNSPSC 51284400: Fifth generation cephalosporins

This classification denotes the original variety of broad-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term CEPHALOSPORIN. These differ from other Cephalosporins both in their chronological development and that these are effective against Methicillin-Resistant Staphylococcus aureus, a strain of Staphylococcus aureus that is non-susceptible to the action of methicillin.

The mechanism of resistance usually involves modification of normal or the presence of acquired penicillin binding proteins.

UNSPSC 51284400 Fifth generation cephalosporins is a Class code that encompasses pharmaceutical procurement by state and local health agencies, though the recent opportunities block shows limited direct solicitation activity under this specific classification. The opportunities posted show state and local health departments and counties acquiring pharmaceutical products through both competitive bidding processes and piggyback cooperative purchasing vehicles. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets (completion date August 28, 2026), and Seminole County, Florida released an IFB for Naloxone and Safe Drug Deactivation Systems with a response deadline of July 26, 2023. These opportunities reflect state departments of public health and county health authorities as primary issuing bodies, typically procuring through IFB or piggyback cooperative-purchasing frameworks with initial contract terms of 12 to 24 months and optional renewal periods.

Recent activity concentrates in Florida and Illinois, with state-level health agencies driving larger-dollar pharmaceutical warehouse awards on annual or multi-year cycles. The Illinois procurement demonstrates use of established cooperative purchasing consortia (MMCAP Infuse) to aggregate demand across jurisdictions and secure volume pricing, with contracts running 12 months plus two additional renewal options. The Seminole County opportunity shows county-level procurement of therapeutic pharmaceuticals and related systems for community health initiatives, with quarterly delivery requirements and fixed-fee pricing structures. Neither opportunity identified explicit set-asides for disadvantaged enterprises, though FEMA compliance and federal procurement standards apply where federal funding is involved. Vendors must maintain standard insurance coverages and workplace certification requirements typical of state and local pharmaceutical supply agreements.